R Jain, S Singh… - US Patent 20,110,195,087, 2011 - freepatentsonline.com The present invention relates to a combination vaccine comprising a mixture of antigens for protection against diseases such as diphtheria, tetanus, whole cell pertussis and polio. The present invention also relates to inclusion of one or more antigens in the said combination vaccine, for ... Cached
TJ Brickman, CA Cummings, SY Liew… - Journal of …, 2011 - Am Soc Microbiol Serological studies of patients with pertussis and the identification of antigenic Bordetella pertussis proteins support the hypothesis that B. pertussis perceives an iron starvation cue and expresses multiple iron source utilization systems in its natural human host environment. ... All 2 versions
JM Kemmeren, SS Timmer, NAT van der Maas… - Vaccine, 2011 - Elsevier A cross-sectional study was conducted to assess the difference in tolerability of a DTaP-IPV booster in four-year-old children primed in infancy with either three doses DTaP-IPV-Hib (aP-primed) or three doses of DTwP-IPV-Hib (wP-primed). Parents were asked to report in a ... Related articles - All 2 versions
SR Paccani, F Finetti, M Davi, L Patrussi… - The Journal of …, 2011 - jem.rupress.org The Bordetella pertussis adenylate cyclase toxin (CyaA) assists infection by potently suppressing the host immune response. Although CyaA effectively targets T lymphocytes, its putative receptor on these cells is unknown. Here, we show that CyaA binds to T cells via the β 2 integrin ... Cited by 1 - Related articles - All 3 versions
AF Trofa, NP Klein, IM Paul… - The Pediatric …, 2011 - journals.lww.com Methods: This was an open-labeled, multicenter study with healthy subjects enrolled and randomized (1:1:1) into 3 treatment groups. A total of 394 subjects received the first study vaccinations at 15 months of age. Group HAV (N = 135) received 2 doses of HAV vaccine 6 to 9 months ... Cited by 1 - Related articles - All 4 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
